List of Tables

Table 1. Omalizumab Biosimilars Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Omalizumab Biosimilars Market Restraints

Table 3. Omalizumab Biosimilars Market Trends

Table 4. Omalizumab Biosimilars Industry Policy

Table 5. Global Omalizumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Omalizumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Omalizumab Biosimilars Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Omalizumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Omalizumab Biosimilars Average Selling Price (ASP) by Company, (2020-2025) & (USD/Unit)

Table 10. Global Omalizumab Biosimilars Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Omalizumab Biosimilars Mergers & Acquisitions, Expansion Plans

Table 12. Global Omalizumab Biosimilars Manufacturers Product Type

Table 13. Head Office and Omalizumab Biosimilars Production Site of Key Manufacturer

Table 14. Omalizumab Biosimilars Capacity of Major Manufacturers and Future Plan

Table 15. China Omalizumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Omalizumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Omalizumab Biosimilars Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Omalizumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Omalizumab Biosimilars Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Omalizumab Biosimilars Production by Region, 2020-2025, (K Units)

Table 21. Global Omalizumab Biosimilars Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Omalizumab Biosimilars Upstream (Raw Materials)

Table 23. Global Omalizumab Biosimilars Typical Customers

Table 24. Omalizumab Biosimilars Typical Distributors

Table 25. by Type, Global Omalizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Omalizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Omalizumab Biosimilars Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Omalizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Omalizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Omalizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Omalizumab Biosimilars Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Omalizumab Biosimilars Sales Quantity Market Share, 2020-2031

Table 35. Roche Company Information, Head Office, Market Area, and Industry Position

Table 36. Roche Omalizumab Biosimilars Models, Specifications, and Application

Table 37. Roche Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 38. Roche Company Profile and Main Business

Table 39. Roche Recent Developments

Table 40. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 41. Novartis Omalizumab Biosimilars Models, Specifications, and Application

Table 42. Novartis Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 43. Novartis Company Profile and Main Business

Table 44. Novartis Recent Developments

Table 45. Glenmark Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Glenmark Pharmaceuticals Omalizumab Biosimilars Models, Specifications, and Application

Table 47. Glenmark Pharmaceuticals Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 48. Glenmark Pharmaceuticals Company Profile and Main Business

Table 49. Glenmark Pharmaceuticals Recent Developments

Table 50. Selexis Company Information, Head Office, Market Area, and Industry Position

Table 51. Selexis Omalizumab Biosimilars Models, Specifications, and Application

Table 52. Selexis Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 53. Selexis Company Profile and Main Business

Table 54. Selexis Recent Developments

Table 55. Generium Company Information, Head Office, Market Area, and Industry Position

Table 56. Generium Omalizumab Biosimilars Models, Specifications, and Application

Table 57. Generium Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 58. Generium Company Profile and Main Business

Table 59. Generium Recent Developments

Table 60. CuraTeQ Company Information, Head Office, Market Area, and Industry Position

Table 61. CuraTeQ Omalizumab Biosimilars Models, Specifications, and Application

Table 62. CuraTeQ Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 63. CuraTeQ Company Profile and Main Business

Table 64. CuraTeQ Recent Developments

Table 65. Celltrion Healthcare Company Information, Head Office, Market Area, and Industry Position

Table 66. Celltrion Healthcare Omalizumab Biosimilars Models, Specifications, and Application

Table 67. Celltrion Healthcare Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 68. Celltrion Healthcare Company Profile and Main Business

Table 69. Celltrion Healthcare Recent Developments

Table 70. Alvotech Company Information, Head Office, Market Area, and Industry Position

Table 71. Alvotech Omalizumab Biosimilars Models, Specifications, and Application

Table 72. Alvotech Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 73. Alvotech Company Profile and Main Business

Table 74. Alvotech Recent Developments

Table 75. BiosanaPharma Company Information, Head Office, Market Area, and Industry Position

Table 76. BiosanaPharma Omalizumab Biosimilars Models, Specifications, and Application

Table 77. BiosanaPharma Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 78. BiosanaPharma Company Profile and Main Business

Table 79. BiosanaPharma Recent Developments

Table 80. Mabpharm Company Information, Head Office, Market Area, and Industry Position

Table 81. Mabpharm Omalizumab Biosimilars Models, Specifications, and Application

Table 82. Mabpharm Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 83. Mabpharm Company Profile and Main Business

Table 84. Mabpharm Recent Developments

Table 85. CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 86. CSPC Pharmaceutical Group Omalizumab Biosimilars Models, Specifications, and Application

Table 87. CSPC Pharmaceutical Group Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 88. CSPC Pharmaceutical Group Company Profile and Main Business

Table 89. CSPC Pharmaceutical Group Recent Developments

Table 90. Biomabs Company Information, Head Office, Market Area, and Industry Position

Table 91. Biomabs Omalizumab Biosimilars Models, Specifications, and Application

Table 92. Biomabs Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 93. Biomabs Company Profile and Main Business

Table 94. Biomabs Recent Developments

Table 95. HisunPharm Company Information, Head Office, Market Area, and Industry Position

Table 96. HisunPharm Omalizumab Biosimilars Models, Specifications, and Application

Table 97. HisunPharm Omalizumab Biosimilars Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2020-2025

Table 98. HisunPharm Company Profile and Main Business

Table 99. HisunPharm Recent Developments

List of Figures

Figure 1. Omalizumab Biosimilars Picture

Figure 2. Global Omalizumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Omalizumab Biosimilars Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Omalizumab Biosimilars Average Selling Price (ASP), (2020-2031) & (USD/Unit)

Figure 5. China Omalizumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Omalizumab Biosimilars Sales Quantity (K Units) & (2020-2031)

Figure 7. China Omalizumab Biosimilars Average Selling Price (ASP), (USD/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Omalizumab Biosimilars Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Omalizumab Biosimilars Market Share of Global, 2020-2031

Figure 10. Global Omalizumab Biosimilars Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Omalizumab Biosimilars Key Participants, Market Share, 2024

Figure 12. Global Omalizumab Biosimilars Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Omalizumab Biosimilars Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Omalizumab Biosimilars Production Market Share & Forecast by Region, 2020-2031

Figure 15. Omalizumab Biosimilars Industry Chain

Figure 16. Omalizumab Biosimilars Procurement Model

Figure 17. Omalizumab Biosimilars Sales Model

Figure 18. Omalizumab Biosimilars Sales Channels, Direct Sales, and Distribution

Figure 19. 150 mg/mL

Figure 20. 75 mg/0.5 mL

Figure 21. by Type, Global Omalizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Omalizumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 24. by Type, Global Omalizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Omalizumab Biosimilars Average Selling Price (ASP), 2020-2031, (USD/Unit)

Figure 26. Persistent Asthma

Figure 27. Nasal Polyps

Figure 28. Chronic Idiopathic Urticaria

Figure 29. by Application, Global Omalizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Omalizumab Biosimilars Revenue Market Share, 2020-2031

Figure 31. by Application, Global Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 32. by Application, Global Omalizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Omalizumab Biosimilars Price, 2020-2031, (USD/Unit)

Figure 34. By Region, Global Omalizumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Omalizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 36. North America Omalizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Omalizumab Biosimilars Consumption Value Market Share, 2024

Figure 38. Europe Omalizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Omalizumab Biosimilars Consumption Value Market Share, 2024

Figure 40. Asia Pacific Omalizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Omalizumab Biosimilars Consumption Value Market Share, 2024

Figure 42. South America Omalizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Omalizumab Biosimilars Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Omalizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 46. by Type, United States Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, Europe Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, China Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Japan Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, South Korea Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Southeast Asia Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, India Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Omalizumab Biosimilars Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Middle East & Africa Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Omalizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches